Jump to content

User:Biosthmors/Things

From Wikipedia, the free encyclopedia
Some things I could ponder or do
[edit]




Questions

Should venous thrombosis be a definition and a disambiguation to deep vein thrombosis, superficial vein thrombosis, and venous thromboembolism? Should superficial thrombophlebitis redirect to superficial vein thrombosis? Does thrombophlebitis deserve its own article? Probably more than phlebothrombosis does

Is the National Acupuncture Detoxification Association notable?

Potential secondary sources
[edit]
  • Darvall K, Bradbury A (2012). "Pathways for venous thromboembolic prophylaxis in medical and surgical patients". Phlebology. 27 Suppl 2 (2_suppl): 33–42. doi:10.1258/phleb.2012.012S36. PMID 22457303.
  • Romualdi E, Dentali F, Rancan E, Squizzato A, Steidl L, Middeldorp S; et al. (2013). "Anticoagulant therapy for venous thromboembolism during pregnancy: A systematic review and a meta-analysis of the literature". J Thromb Haemost. 11 (2): 270–81. doi:10.1111/jth.12085. PMID 23205953. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
  • Fox BD, Kahn SR, Langleben D; et al. (2012). "Efficacy and safety of novel oral anticoagulants for treatment of acute venous thromboembolism: Direct and adjusted indirect meta-analysis of randomised controlled trials". BMJ. 345: e7498. doi:10.1136/bmj.e7498. PMC 3496553. PMID 23150473. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: article number as page number (link) CS1 maint: multiple names: authors list (link)
  • Greer DM, Styer AK, Toth TL; et al. (2010). "Case records of the Massachusetts General Hospital. Case 21-2010. A request for retrieval of oocytes from a 36-year-old woman with anoxic brain injury". N Engl J Med. 363 (3): 276–83. doi:10.1056/NEJMcpc1004360. PMID 20647203. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  • "Venous thromboembolic diseases: The management of venous thromboembolic diseases and the role of thrombophilia testing". National Institute for Health and Clinical Excellence. 2012.
  • Baglin T (2012). "Inherited and acquired risk factors for venous thromboembolism". Semin Respir Crit Care Med. 33 (2): 127–37. doi:10.1055/s-0032-1311791. PMID 22648484.
  • Baglin T, Bauer K, Douketis J; et al. (2012). "Duration of anticoagulant therapy after a first episode of an unprovoked pulmonary embolus or deep vein thrombosis: guidance from the SSC of the ISTH". J Thromb Haemost. 10 (4): 698–702. doi:10.1111/j.1538-7836.2012.04662.x. PMID 22332937. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
Incident vs. recurrent
Vandalism on medically-related featured articles
  • [10] 37 min, 13 Feb 2012, Lung cancer.
  • [11] 54 min, 6 Mar 2012, Helicobacter pylori.
  • [12] 102 min, 7 Mar 2012, Schizophrenia.
  • [13] 91 min, 30 Mar 2012, Coeliac disease.
  • [14] 148 min, 12 April 2012, Menstrual cycle.
Miscellaneous
[edit]

Vandalism on medically-related good articles 111 min, 8 Mar 2012, Hepatitis B; Bugs: [15], [16]&[17]; Promotion; Commentary on neutrality, A good contribution: Talk:Malaria/GA2; FA advice; From a reader, a thank you; [18]; assignment[19]

WikiProject Medicine assessment statistics
Medicine articles by quality and importance
Quality Importance
Top High Mid Low NA ??? Total
FA 9 12 20 23 64
FL 2 4 10 16
FM 81 81
GA 25 52 110 228 1 416
B 50 454 1,389 1,984 60 3,937
C 17 421 3,410 8,761 1 222 12,832
Start 116 4,630 19,175 4 319 24,244
Stub 1,400 10,229 1 233 11,863
List 22 278 615 50 965
Category 12,815 12,815
Disambig 181 181
File 489 489
Portal 537 537
Project 173 173
Redirect 483 958 6,123 7,564
Template 1,482 1,482
NA 2 2
Draft 2 6 496 504
Assessed 101 1,079 11,726 41,989 22,385 885 78,165
Unassessed 38 1 80 119
Total 101 1,079 11,726 42,027 22,386 965 78,284
WikiWork factors (?) ω = 256,375 Ω = 4.80

worklist • log • category

Translation task force assessment statistics
WikiProject Medicine Translation Task Force articles by quality and importance
Quality Importance
Top High Mid Low NA ??? Total
FA 2 5 7
GA 21 17 38
B 4 146 2 152
C 4 74 1 3 2 84
Start 7 1 8
Stub 1 1
Category 13 13
Project 3 3
NA 1 1
Assessed 31 249 3 4 17 3 307
Unassessed 1 1
Total 31 249 3 4 17 4 308
WikiWork factors (?) ω = 914 Ω = 3.15

worklist • log • category


Did you know

Articles for deletion

(15 more...)

Proposed deletions

Categories for discussion

Redirects for discussion

(10 more...)

Files for discussion

Miscellany for deletion

Featured article candidates

Good article nominees

(3 more...)

Good article reassessments

Requests for comments

Peer reviews

Requested moves

Articles to be split

(12 more...)

Articles for creation

(97 more...)


Medicine

[edit]

Insilicos

[edit]
Insilicos (edit | talk | history | protect | delete | links | watch | logs | views) – (View AfD | edits since nomination)
(Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL)

No significant coverage for NCORP. 海盐沙冰 / aka irisChronomia / Talk 08:15, 26 June 2026 (UTC)

Joseph A. Bonanno

[edit]
Joseph A. Bonanno (edit | talk | history | protect | delete | links | watch | logs | views) – (View AfD | edits since nomination)
(Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL)

IP user ~2026-35132-87 gave the following explanation at WT:AFD:

[Joseph A. Bonanno's] entire description is, an American Optometrist. This man is not notable enough to have his own Wikipedia page. This man is just a regular optometrist with nothing notable mentioned in the whole article. The site also lacks secondary sources

FaviFake (talk) 20:06, 25 June 2026 (UTC)

comment - I am assuming that the IP nominator did not due any WP:BEFORE research, since a quick search reveals what Nat Gertler detailed. Bonnano was a dean of a major public university (IU)'s optometry school for 13 years, which itself doesn't qualify under WP:NACADEMIC, although it points to him being more than your friendly optometrist down the road. Yojo98 (talk) 23:55, 25 June 2026 (UTC)

Europ Assistance

[edit]
Europ Assistance (edit | talk | history | protect | delete | links | watch | logs | views) – (View AfD | edits since nomination)
(Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL)

Corporate spam for a French travel insurance company. This article is a declared paid contribution which bypassed AfC, and appears to be AI-generated. I previously nominated this for speedy deletion, following which it was draftified by Deb, before being moved back to mainspace by a different user who creates similar brochures. All that aside, I don't see a whole lot of substance in the references anyway. Another one for the pile. MediaKyle (talk) 16:11, 24 June 2026 (UTC)

Sorry about that, but Europ Assistance is a company I'd heard of so I gave them the benefit of the doubt. User:Balabush should be given a chance to explain why s/he thought that the article was suitable for mainspace. Deb (talk) 17:28, 24 June 2026 (UTC)
  • Delete: Sources in the FR wiki (the first two) are insurance trade magazines, so not used to show notability. I can only find press releases [20]. Merge or redirect to Generali perhaps? Oaktree b (talk) 20:22, 24 June 2026 (UTC)
Comment (article author; paid/COI, disclosed on my user page and talk page).
I will not take a position on this matter and leave the decision to uninvolved contributors. I acknowledge that the article was written as part of a paid assignment. I have added new independent secondary sources.
Regarding the trade press: two of the three most reliable sources are not publications specializing in insurance, but rather the leading general business dailies in their respective countries.
“Les Échos” (January 16, 2018), “How Europ Assistance Plans to Accelerate”, the leading French business daily;
“Il Sole 24 Ore” (December 28, 2019), a feature on the group’s digital activities, Italy’s leading business daily.
“L’Argus de l’Assurance” is, as noted, a specialized publication (although its article cites its own sources, not a press release). Pandananas (talk) 09:08, 25 June 2026 (UTC)
Merge/Redirect to Assicurazioni Generali (under their France & Global Business Activities unit). Merging the verified historical facts into it's parent company's article satisfies WP:CORP but removes a standalone piece of corporate marketing promotion. MissBVCC (talk) 14:34, 25 June 2026 (UTC)
Merge/redirect to Assicurazioni Generali. As the editor who moved this to mainspace, I'll note I have no objection to a merge. the sourcing is largely primary, and the verifiable history fits fine in the parent article. Balabush (talk) 05:40, 26 June 2026 (UTC)

Ladan Eshkevari

[edit]
Ladan Eshkevari (edit | talk | history | protect | delete | links | watch | logs | views) – (View AfD | edits since nomination)
(Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL)

Fails WP:NACADEMIC and WP:GNG. Mid-career nurse anesthetist with routine credentials. Created by the same new editor as the Avesta article in October 2025. Clear UPE/COI pattern. WP:BEFORE turns up nothing better. LogosUnspoken (talk) 23:18, 23 June 2026 (UTC)

  • Note: this discussion has been included in the AfD sorting lists for the following topics: Suspected AI-generated articles, Iran, India, Maryland, New York, and Washington, D.C.. WCQuidditch ☎ ✎ 03:13, 24 June 2026 (UTC)
  • Delete> Weak keep. Negligible as a scholar, as far as I can see. It's not easy to estimate her h from the data at Google Scholar, but it seems likely to be of the order of 15 or less, not enough for a senior professor. Athel cb (talk) 17:29, 24 June 2026 (UTC)
  • Weak Delete, but I am ready to change this to a Weak Keep. The membership of AANA is more than 60K, so being editor-in-chief of their journal (founded in 1933) may pass WP:NPROF#C8. Being elected as a Fellow may qualify under #C3. The big problem is that the sources do not verify the claims, and many are dead links. None of the scanners I routinely use believe this is AI, and the nom has not provided any evidence for UPE/COI or rationale for tagging this as AI. Note: both the page creator and nom have relatively few edits which raises red flags in my mind. I am very much on the fence here, and feel this needs more investigation.Ldm1954 (talk) 08:52, 26 June 2026 (UTC)
    Having done a stack of cleanup, refbombing removal and source merging I have changed my vote. The claims in the page about her being a Fellow & Editor-in-Chief are correct, although the referencing may need more work. I see no major AI indications, I am highly dubious that the nom really did a WP:BEFORE, I think something else is going on here and at Wikipedia:Articles for deletion/Avesta Ketamine and Wellness. If there was not an existing vote by @Athel cb I would consider this as eligible for an SK2 Speedy Keep. Ldm1954 (talk) 10:25, 26 June 2026 (UTC)
  • In view of Ldm1954's post I have changed my vote to Weak Keep. Athel cb (talk) 13:35, 26 June 2026 (UTC)

Lactosylceramide alpha-2,3-sialyltransferase

[edit]
Lactosylceramide alpha-2,3-sialyltransferase (edit | talk | history | protect | delete | links | watch | logs | views) – (View AfD | edits since nomination)
(Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL)

I propose merging reverse merging (see comment below) to ST3GAL5 because they are aliases of the same enzyme. ST3GAL5 is the most common alias. "GM3 synthase" is an alternative name that shows up in some places (mostly not primary academic research) but I think it's people backtracking based on a well-known pathology "GM3 deficiency syndrome" or Salt and pepper syndrome, deficiency in a ganglioside called GM3 synthesized by this enzyme. Mausfield (talk) 18:09, 22 June 2026 (UTC)

  • Note: this discussion has been included in the AfD sorting lists for the following topics: Biology, Chemistry, and Medicine. Mausfield (talk) 18:09, 22 June 2026 (UTC)
  • Better merge in the oposite direction i.e. merge ST3GAL5 to Lactosylceramide alpha-2,3-sialyltransferase, for several reasons. First, ST3GAL5 is not the name of an enzyme, it's an incorrect name for a gene that codes for an enzyme. Even the article on ST3GAL5 doesn't pretend that it's the name of an enzyme. It calls it lactosylceramide alpha-2,3-sialyltransferase. Second, the gene name, like most gene names, provides almost no clue as to what its product does, whereas the sensible name does indicate what the enzyme does. Third, the gene name isn't even given correctly: it is hST3Gal V, not ST3GAL5 (capitalization is important in chemical names); at least, that's what Kim et al. 2001 call it in the cited paper. Finally, it gives it an obsolete EC number, EC 2.4.3.9, not EC 2.4.99.9 Athel cb (talk) 20:27, 22 June 2026 (UTC)
Agree with previous user, merge ST3GAL5 to Lactosylceramide alpha-2,3-sialyltransferase for the reasons just given. Neither article is in good shape, but combined they could be a useful stub article. WeirdNAnnoyed (talk) 22:07, 22 June 2026 (UTC)
Reverse merge per above FaviFake (talk) 16:06, 23 June 2026 (UTC)
Seems the clear consensus is the reverse, from more knowledgable people, which I'm happy to agree with, as I did not have a strong opinion on the direction, classification is not my area. I do have a background concern that what may indeed be an "incorrect" name according to biochemists may still be the most popular name in common usage (which in this case is clinical research), so maybe a redirect is warranted? Regarding article state, I have some stuff ready, but I wanted to submit this first. Mausfield (talk) 22:37, 26 June 2026 (UTC)

EMRBots

[edit]
EMRBots (edit | talk | history | protect | delete | links | watch | logs | views) – (View AfD | edits since nomination)
(Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL)

Was not able to find any significant-coverage, independent sources in WP:BEFORE. Some independent sources came up, but were all using the subject in their methods rather than actually covering the subject. Every significant-coverage source I found was by the creator of the subject (who also created the article). Separately, the article has a lot of problems. If we decide on a keep, I'll spend some time editing down a lot of superfluous info in the article. In solidarity, Eyesinthefire (talk) 23:40, 20 June 2026 (UTC)

Erica Spatz

[edit]
Erica Spatz (edit | talk | history | protect | delete | links | watch | logs | views) – (View AfD | edits since nomination)
(Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL)

Does not meet WP:N including WP:PROF including WP:NACADEMIC. Is an associate professor - not even recognized by employer to be a full professor - does not have significant coverage separate from her employer that is promotional and fails to cite sufficient sources to demonstrate the notability. Is clearly not notable. Quaerens-veritatem (talk) 02:58, 19 June 2026 (UTC)

  • Note: this discussion has been included in the AfD sorting lists for the following topics: Academics and educators, Women, Medicine, Israel, New York, and Tennessee. WCQuidditch ☎ ✎ 02:57, 19 June 2026 (UTC)
  • Weak delete. It is true that is unusual to have articles on an associate professor — even being an assoc. prof. at Yale doesn't mean notability. However, I think that not even recognized by employer to be a full professor is a little harsh. We do indeed have articles on associate professors who have had a significant research impact. There is some significant coverage of the subject [21], so I disagree that the subject is clearly not notable, but there is only little else in terms of significant secondary coverage outside of that article, so it seems WP:TOOSOON. Jay-GH 06:50, 21 June 2026 (UTC)
  • Weak keep h-index is decent [22]. ~2026-36151-63 (talk) 16:54, 21 June 2026 (UTC)
Relisted to generate a more thorough discussion and clearer consensus.
Please add new comments below this notice. Thanks, Svartner (talk) 05:44, 26 June 2026 (UTC)

Jaydev Panchwagh

[edit]
Jaydev Panchwagh (edit | talk | history | protect | delete | links | watch | logs | views) – (View AfD | edits since nomination)
(Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL)

Non notable medical doctor. Sources are either routine or paid brand affiliates. Fails GNG. Thilsebatti (talk) 14:35, 18 June 2026 (UTC)

Relisted to generate a more thorough discussion and clearer consensus.
Please add new comments below this notice. Thanks, BhikhariInformer‬ 📮 (Ping me or else I won't see it) 15:58, 25 June 2026 (UTC)

Makim Nikitin

[edit]
Makim Nikitin (edit | talk | history | protect | delete | links | watch | logs | views) – (View AfD | edits since nomination)
(Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL)

Page on a Russian biophysics academic whose major claim to notability is, to quote, “molecular commutation”—a discovery that revises the classical double helix model. I am not convinced of a pass of WP:NPROF, so sending to AfD for more discussion. From standard citation metrics, his Scopus h-factor of 35 with 3K cites is too low for #C1a in nanotechnology, a high citation area. The case for a pass depends, IMO on the "discovery" and an associated 2024 State Prize of the Russian Federation and whether this qualifies for a pass of #C1b. Since the 2023 Nature Chemistry paper on it has to date only 80 cites I do not see enough peer recognition that this passes #C1b by itself, it is WP: TOOSOON for such a claim. Ldm1954 (talk) 10:12, 18 June 2026 (UTC)

I think that the fact that he is laureate of the 2024 State Prize of the Russian Federation is a good reason why this article has notability and should be kept, regarding his "discovery", if anything seems suspicious or not supported enough with reliable citations, this section can be removed. Rakoon (talk) 17:06, 19 June 2026 (UTC)
Relisted to generate a more thorough discussion and clearer consensus.
Please add new comments below this notice. Thanks, CycloneYoris talk! 01:26, 26 June 2026 (UTC)
  • Delete. I see nothing to indicate notability. Athel cb (talk) 08:47, 26 June 2026 (UTC)
  • Comment. Searching for him isn't helped by the bad transcription of his name in the English Wikipedia: Максим could be Maksim or Maxim, but never Makim. Athel cb (talk) 08:58, 26 June 2026 (UTC)
    You are right, it should be Maxim as that is how he is listed at Scopus and GS. We can move it later if he survives the AfD. Ldm1954 (talk) 09:15, 26 June 2026 (UTC)

Flintstones Chewable Vitamins

[edit]
Flintstones Chewable Vitamins (edit | talk | history | protect | delete | links | watch | logs | views) – (View AfD | edits since nomination)
(Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL)

Merge to List of The Flintstones media's section "In popular culture", where it already has a paragraph. The sources in this article are pretty bad, almost entirely primary with one AP story about Betty being added in the 90s. A WP:BEFORE search turned up almost nothing that wasn't marketing material, with an article on Mentalfloss (https://www.mentalfloss.com/article/26157/brief-history-flintstones-vitamins) and a 2015 article from Newsweek (https://www.newsweek.com/problem-childrens-multivitamins-supplements-324545) (see WP:NEWSWEEK) both missing the mark. There is one WP:RS from Marketplace (https://www.marketplace.org/story/2022/12/02/why-are-flintstones-vitamins-and-cereal-still-popular-decades-after-the-show-ended), a public radio publication, but I think two sources here is weak and not justifying of a WP:CFORK Yojo98 (talk) 16:01, 12 June 2026 (UTC)

  • Note: this discussion has been included in the list of Products-related AfD discussions. Spiderone(Talk to Spider) 16:27, 12 June 2026 (UTC)
  • Leaning keep and improve (though probably move to just Flintstones Vitamins, currently redirecting there). Vitamins are not "media", they are a commercial product with an end use and impact distinct from their use of a trademark as a sales mechanism. BD2412 T 19:27, 12 June 2026 (UTC)
    Agree that Flintstones Vitamins would be more appropriate under WP:COMMONNAME. I would say that to have its own page on the merits you described, we would need proof of it fulfilling the WP:GNG requirements. Yojo98 (talk) 19:49, 12 June 2026 (UTC)
  • Neutral comment Why would we redirect a nutritional supplement like a children's vitamin to a 'in pop culture' article? It should go to the manufacturers' article first over what would just be a bare mention of the vitamin's existence in the former. Nathannah • 📮 21:43, 12 June 2026 (UTC)
    @Nathannah: My understanding is that the manufacturer changed at one point, although Bayer does seem to be the long-term stable manufacturer now. Still. for a company of that size, I don't know that the one line mentioning this product is a helpful redirect target for readers. BD2412 T 23:47, 12 June 2026 (UTC)
  • Merge – Agree it doesn't need to have a standalone article, and I don't find the proposed target to be too inappropriate. FaviFake (talk) 08:09, 13 June 2026 (UTC)
    I won't lose sleep if this is merged. Cheers! BD2412 T 12:29, 13 June 2026 (UTC)
  • WP:INPOPCULTURE sections are usually something to avoid unless there's significant coverage. The paragraph is not even sourced. Also, the vitamins aren't a form of media. – The Grid (talk) 15:15, 15 June 2026 (UTC)
    Agree with your points here, it just seemed like the most apt merge candidate for me. I'm also comfortable with a straight-up delete. Sources could be merged from the current stand-alone article (the AP and marketplace source) to replace the DVD citation that's currently in the list article Yojo98 (talk) 15:49, 15 June 2026 (UTC)
  • Merge into The Flintstones - potentially as a new "Merchandise" section? That way it could also be home to a mention of Pebbles (cereal). However I'm not wedded to this idea and I'd support a straight delete too. Netstars22 (talk to me!) 21:14, 17 June 2026 (UTC)
    • @Netstars22: Deletion is not proposed in the nomination, and should be off the table given that there are clearly sources to show the subject to be noteworthy within the context of the franchise, even if arguably not independently notable. BD2412 T 23:53, 17 June 2026 (UTC)
      • Ah yes, I do see that it's specifically a merge nom now. Updating my earlier nom to note that but I will maintain my opinion on a merge target. Netstars22 (talk to me!) 00:04, 18 June 2026 (UTC)
  • Keep - for children of Generation X, this product was a Brand-name status symbol for conspicuous consumption. If you casually mentioned in the School Cafeteria that you had taken your Flintstone Vitamin that morning, as you fiddled with the alligator on your Lacoste sweater, you were telegraphing your middle-class status, as much as you name-dropped your dad's wood-paneled station wagon, your older brother's frat at Columbia University, your NFL-branded duvet that grandma bought you, your new 10-speed bike, or your mom's new Bicentennial couch from Ethan Allen. The subject of this article was not just about nutrition. Bearian (talk) 12:57, 18 June 2026 (UTC)
    Hi Bearian, while I appreciate your anecdotal comment, it would be helpful if you linked to any WP:RS that support the comment you made here. The issue at hand is that the article contains almost none of the information you provided and is mostly a list of products with WP:PRIMARY sources. Yojo98 (talk) 13:09, 18 June 2026 (UTC)
  • Merge While I am sympathetic to Bearian (I too used to take flinstones vitamins) but I googled (with the hope I could find some sources and couldn't find anything. Agnieszka653 (talk) 21:53, 19 June 2026 (UTC)
Relisted to generate a more thorough discussion and clearer consensus.
Please add new comments below this notice. Thanks, Doczilla Ohhhhhh, no! 21:57, 19 June 2026 (UTC)
  • merge to the Flintsones instead, this isn't a media item. It's a medical item. Not much for sourcing, this in the Saturday Evening Post [23], but that's about the best I got in my searches. Oaktree b (talk) 01:11, 20 June 2026 (UTC)
  • Comment: Pages 85-91 of this FTC report discusses how companies create their product and market them to kids as they will be the "first" to use it, albeit not specifically for these vitamins; there are other original research papers about this phenomenon. Bearian (talk) 17:23, 26 June 2026 (UTC)
Relisted to generate a more thorough discussion and clearer consensus.
Relisting comment: I see consensus against a standalone article, but a lack of agreement as to a merger target: should we use the media list or the main article?
Please add new comments below this notice. Thanks, Vanamonde93 (talk) 18:48, 26 June 2026 (UTC)
I don't have a strong preference for merge target. I nominated to the media list since that's already the content fork off of the main Flintstones page. I understand it's imperfect given that this isn't media exactly, but it would feel odd in the main page too given the section heading there is "other media". Right now I don't think there's enough WP:RS for an entirely new section in the main Flintstones page Yojo98 (talk) 19:12, 26 June 2026 (UTC)
  • Keep: Flintstones vitamins have been around for a long time. -- NYC Guru (talk) 23:23, 26 June 2026 (UTC)

Surgery

[edit]

Proposed deletions

[edit]

An automatically generated list of proposed deletions and other medicine-related article alerts can be found at Wikipedia:WikiProject Medicine/Article alerts, Wikipedia:WikiProject Pharmacology/Article alerts, and Wikipedia:WikiProject Neuroscience/Article alerts



Deletion Review

[edit]
Retrieved from "https://en.wikipedia.org/w/index.php?title=User:Biosthmors/Things&oldid=1023540647"